Functional vasopressin V1 type receptors are present in variant as well as classical forms of small-cell carcinoma

Peptides

Volumn 18, Issue 7, 1997, Pages 985-993

  North, William G ^a   Fay, Michael J ^a   Longo, Kenneth ^a   Du, Jinlin ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Calcium mobilization; Inositol phosphates; mRNA sequences; Small cell carcinoma; Vasopressin V1 receptor

Indexed keywords

CALCIUM; INOSITOL PHOSPHATE; MESSENGER RNA; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; PRIMER DNA; RNA; VASOPRESSIN RECEPTOR;

ARTICLE; CALCIUM MOBILIZATION; CANCER CELL CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LUNG SMALL CELL CANCER; MOLECULAR CLONING; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; CELL CULTURE; GENETIC VARIABILITY; GENETICS; LUNG TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SMALL CELL CARCINOMA;

AMINO ACID SEQUENCE; BASE SEQUENCE; CALCIUM; CARCINOMA, SMALL CELL; CLONING, MOLECULAR; DNA PRIMERS; HUMANS; INOSITOL PHOSPHATES; LUNG NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0030608992     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00072-7     Document Type: Article

References (39)

1. + RNA. Biotechniques. 6:1988;114-116.
2. Bepler G., Rotsch M., Jaques G., Haeder M., Heymanns J., Hartogh G., Kiefer P., Havemann K. Peptides and growth factors in small cell lung cancer Production, binding sites, and growth effects. J. Cancer Res. Clin. Oncol. 114:1988;235-244.
3. Bergh J. C. S. Gene amplification in human lung cancer The myc family genes and other proto-oncogens and growth factor genes. Am. Rev. Respir. Dis. 142:1990;S20-S26.
4. Berridge M. J., Dawson R. M. C., Downes C. P., Heslop J. P., Irvine R. F. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212:1983;473-482.
5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem. 72:1976;248-254.
6. Brambilla E., Moro D., Gazzeri S., Brichon P. Y., Nagy-Mignotte H., Morel F., Jacrot M., Brambilla C. Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J. Clin. Oncol. 9:1991;50-61.
7. Bunn P. A., Dienhart D. G., Chan D., Puck T. T., Tagawa M., Jewett P. B., Braunschweiger E. Neuropeptides stimulation of calcium flux in human lung cancer cells Delineation of alternative pathways. Proc. Natl. Acad. Sci. USA. 87:1990;2162-2166.
8. Bunn P. A., Dienhart D. G., Chan D., Tagawa M., Jewett P. Effects of neuropeptides on human lung and breast cancer cells. Monogr. Natl. Cancer Inst. 13:1992;145-151.
9. Carney D. N., Gazdar A. F., Bepler G., Guccion J. G., Marangos P. J., Moody T. W., Zweig M. H., Minna J. D. Establishment and identification of small cell lung cancer cells lines having classic and variant features. Cancer Res. 45:1985;2913-2923.
10. Cuttita F., Carney D. N., Mulshine J., Moody T. W., Fedorko J., Fischler A., Minna J. D. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature. 316:1985;823-826.
11. 1a-receptors in variant SCCL. Cancer Lett. 82:1994;167-174.
12. Friedmann A. S., Malott K. A., Memoli V. A., Pai S. I., Yu X., North W. G. Products of vasopressin gene expression in small-cell carcinoma of the lung. Br. J. Cancer. 69:1994;260-263.
13. Gazdar A. F., Carney D. N., Nau M. M., Minna J. D. Characterization of distinctive biochemical, morphological, and growth properties. Cancer Res. 45:1985;2924-2930.
14. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
15. Guillon G., Couraud P. O., Butlen D., Cantau B., Jard S. Size of vasopressin receptors from rat liver and kidney. Eur. J. Biochem. 111:1980;287-294.
16. 1b. J. Biol. Chem. 271:1996;349-354.
17. Hirasawa A., Shibata K., Kotosai K., Tsujimoto G. Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem. Biophys. Res. Commun. 203:1994;72-79.
18. Hong M., Moody T. W. Vasopressin elevates cytosolic calcium in small cell lung cancer cells. Peptides. 12:1991;1315-1319.
19. 2-vasopressin receptor from bovine kidney. In: Gross, P.; Richter, D.; Robertson, G. L., Eds. Vasopressin. Berlin: John Libbey Eurotext; 1993:582.
20. Laemeli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
21. Little C. D., Nau M. N., Carney D. N., Gazda A. F., Minna J. D. Amplification and expression of c-myc oncogene in human lung cancer cell lines. Nature. 306:1983;194-196.
22. Loken M. R., Herzenberg L. A. Analysis of cell populations with a fluorescence-activated cell sorter. Ann. N.Y. Acad. Sci. 254:1975;163-171.
23. Manning M., Stoev S., Chan W. Y., Sawyer W. H. Antagonists of vasopressin and oxytocin A current perspective. Ann. N.Y. Acad. Scs. 689:1993;233-249.
24. 1a arginine vasopressin receptor. Nature. 356:1992;523-526.
25. North W. G., LaRochelle F. T., Hajdar J., Sawyer W. H., Valtin H. Characterization of an antiserum used in a radioimmunoassay for arginine-vasopressin Implications for reference standards. Endocrinology. 103:1978;1976-1984.
26. North W. G. Neuropeptide production by small cell carcinoma Vasopressin and oxytocin as plasma markers of disease. J. Clin. Endocrinol. Metab. 73:1991;1316-1320.
27. North W. G., Yu X. Vasopressin mRNA and neurophysin-related cell-surface antigen (NRSA) in small-cell carcinoma. Peptides. 14:1993;303-307.
28. North W. G., Yu X. Forms of neurohypophysial peptides generated by tumors, and factors regulating their expression. Reg. Peptides. 45:1993;209-216.
29. Sethi T., Rozengurt E. Multiple neuropeptides stimulate clonal growth of small cell lung cancer Effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res. 51:1991;3621-3623.
30. Sethi T., Langdon S., Smyth J., Rozengurt E. Growth of small cell lung cancer cells Stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res. 52:1992;2737s-2742s.
31. Stassen F. L., Schmidt D. B., Papadopoulos M., Sarau H. M. Prolonged incubation with phorbol esters enhanced vasopressin-induced calcium mobilization and polyphosphatidylinositol hydrolysis of vascular smooth muscle cells. J. Biol. Chem. 264:1989;4916-4923.
32. 2+ elevation by muscarinic stimulation without attenuation of inositol 1,4,5-trisphosphate production in human neuroblastoma SK-N-BE(2)C cells. J. Neurochem. 65:1995;2124-2130.
33. 1-vascular vasopressin receptors. Reg. Peptides. 45:1993;79-84.
34. 1a vasopressin receptor. J. Biol. Chem. 269:1994;3304-3310.
35. Waddell W. J. A simple ultraviolet spectrophotometric method for the determination of protein. J. Lab. Clin. Med. 48:1956;311-314.
36. 2 receptor. Amer. Soc. Biochem. Molec. Biol. 270:1995;18523-18530.
37. Woll P. J., Rozengurt E. Neuropeptides as growth regulators. Br. Med. Bull. 45:1989;292-505.
38. Woll P. J., Rozengurt E. Multiple neuropeptides mobilize calcium in small cell lung cancer Effects of vasopressin, bradykinin, cholecystokinin, galanin, and neurotensin. Biochem. Biophys. Res. Commun. 164:1989;66-73.
39. Woods D. J., Monaco M. E. Characterization of the vasopressin receptor on WRK-1 cells. Mol. Endocrinol. 2:1988;350-354.